Richard Doll’s work helped turn the relationship between smoking and lung cancer from a suspicion into a public health finding that governments could act on. His research with Austin Bradford Hill began with patients in London hospitals; a later study of British doctors strengthened the evidence over time. Doll’s career ranged well beyond tobacco, encompassing occupational disease, radiation research, medical trials and the development of epidemiology as a respected discipline.

A medical career takes shape

William Richard Shaboe Doll was born in Hampton, Middlesex, on 28 October 1912. He attended Westminster School and initially planned to study mathematics at Trinity College, Cambridge. He did not take up an exhibition offered after he failed to secure a scholarship, and instead studied medicine at St Thomas’s Hospital Medical School, graduating in 1937.

Doll was active in the Socialist Medical Association, whose campaigning helped bring about Britain’s post-war National Health Service. During the Second World War he served in the Royal Army Medical Corps, working as a medical specialist on a hospital ship. After the war he returned to St Thomas’s to research asthma. In 1948 he joined a research team led by Francis Avery-Jones at the Central Middlesex Hospital, within the Medical Research Council’s statistical research unit. His early work there examined occupational factors in peptic ulcers; he would later become the unit’s director during a 21-year career.

Testing the link between tobacco and cancer

In 1950, Doll and Bradford Hill investigated lung-cancer patients at 20 London hospitals. Their initial question was whether the disease might be linked to tarmac or motor-car fumes. The patients’ smoking stood out instead. Their paper, published in the British Medical Journal, reported that risk increased with the amount smoked. Doll stopped smoking after the findings emerged.

The hospital investigation and the British doctors study were separate stages of the evidence, not one survey of 40,000 doctors published in 1950. In 1954, Doll and Hill reported findings from a study of about 40,000 doctors followed over 20 years. The results confirmed the association, and the government issued advice that smoking and lung-cancer rates were related. The distinction matters: the initial hospital comparison identified a strong lead, while long-term follow-up helped establish how the risk varied over time.

Doll’s research also addressed disease beyond smoking. In 1955 he reported a case-controlled study that firmly established a relationship between asbestos and lung cancer. His wider work examined occupational causes of cancer, including exposure among workers, and the relationship between radiation and leukaemia. At the Medical Research Council he investigated the effects of radiotherapy using patient mortality data. He also carried out controlled trials of treatments for gastric ulcers.

Building a place for epidemiology

In 1969 Doll moved to Oxford University as Regius Professor of Medicine. Epidemiology was not then held in high regard by all in the medical establishment; at Oxford, Doll helped change that standing. He was a principal figure in establishing Green College in 1979 and became its first warden, retiring in 1983. The college later merged with Templeton College to form Green Templeton College.

His institutional work included helping to found the National Blood Service. He was instrumental in avoiding a system that paid blood donors, as had been adopted in the United States. He also continued cancer research at the Imperial Cancer Research Centre at the John Radcliffe Hospital, working with the Clinical Trial Service Unit. A study with Richard Peto estimated that tobacco, infections and diet together accounted for three-quarters of cancers, a finding that informed World Health Organization conclusions about environmental pollution and cancer.

Doll’s work brought extensive recognition. He was elected a Fellow of the Royal Society in 1966 and knighted in 1971. In 1996 he became a Member of the Order of the Companions of Honour. The inaugural Shaw Prize for Life Sciences and Medicine followed in 2004, recognising his contribution to modern cancer epidemiology. He also received the King Faisal International Prize for medicine jointly with Peto in 2005, and honorary degrees from 13 universities.

Evidence, influence and scrutiny

Doll’s influence extended beyond the laboratory and university. His studies helped provide a basis for public advice on smoking and cancer, while his work on occupational hazards and radiation expanded the reach of preventive medicine. In 2012, BBC Radio Four included him in The New Elizabethans, a series about public figures from Queen Elizabeth II’s reign. A blue plaque was unveiled at his former home in Oxford in 2015. He died at the John Radcliffe Hospital on 24 July 2005, aged 92.

After his death, disclosures about consultancy payments from chemical companies prompted questions about research funding and possible conflicts of interest. The accounts included payments from Monsanto, the Chemical Manufacturers Association, Dow Chemicals and ICI, as well as a public donation from asbestos company Turner and Newall to Green College. Doll had written to an Australian Royal Commission that there was no evidence Agent Orange caused cancer and had published a review on vinyl chloride exposure. His defenders argued that his industry relationships were known within the field, that disclosure norms had changed, and that industry access could help researchers obtain data. Richard Peto also said Doll gave fees from this work to Green College. The funding questions form part of the record of his career, alongside the research that made him prominent.

Why Richard Doll deserves a place in British Legacy

Richard Doll deserves a place in British Legacy because his research helped change the relationship between medical evidence and public action in Britain. The work with Bradford Hill did not consist of a single survey or a lone revelation: a hospital-based investigation in 1950 was followed by long-term observation of British doctors, whose results confirmed the smoking–lung cancer association. That progression made the case more persuasive and helped the government issue public advice. Doll’s career shows how carefully designed epidemiology can identify risks that are difficult to see in an individual patient and make them legible to public institutions.

His contribution was not confined to tobacco. Research on asbestos, occupational cancer and radiation, along with controlled medical trials, extended the evidence base for prevention and treatment. At Oxford, Doll helped establish epidemiology’s place within medical scholarship and played a leading role in founding Green College. He also helped shape the National Blood Service by opposing payment for donations. These achievements connect his British legacy to practical changes in research, medical organisation and public health. The record of funding questions adds a necessary note of scrutiny: trust in health research depends not only on valuable findings, but also on openness about the relationships surrounding them.

Sources

Richard Doll — Wikipedia, revision 1371988880 · Richard Doll — Wikipedia

Adapted in part from Richard Doll by Wikipedia contributors, under CC BY-SA 4.0. Text has been edited and combined with the existing article; this adapted text is shared under the same licence. Contributor history.